logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

TAM JAI INTL(02217) mid-term profit after tax was 36 million Hong Kong dollars, a decrease of 56.1% year-on-year.

date
12:36 14/11/2024
avatar
GMT Eight
Tanzi International (02217) announced that for the six months ended September 30, 2024, it achieved revenue of 1.404 billion...
TAM JAI INTL (02217) announced that, for the six months ended September 30, 2024, the company achieved revenue of 1.404 billion Hong Kong dollars, an increase of 1.23% year-on-year; the net profit after tax was 36 million Hong Kong dollars, a decrease of 56.1% year-on-year.
Related Articles
HK Stock
On June 15, PRU (02378) spent 3.9414 million pounds to repurchase 39.43 thousand shares.
HK Stock
ESSEX BIO-TECH (01061) and HENLIUS have jointly developed the licensed product AURA-2 for the treatment of exudative (wet) age-related macular degeneration. Phase III clinical studies have reached the primary endpoint.
HK Stock
China Resources Gas (01193) spent 16.5474 million Hong Kong dollars to repurchase 1 million shares on June 16.
On June 15, PRU (02378) spent 3.9414 million pounds to repurchase 39.43 thousand shares.
HK Stock
ESSEX BIO-TECH (01061) and HENLIUS have jointly developed the licensed product AURA-2 for the treatment of exudative (wet) age-related macular degeneration. Phase III clinical studies have reached the primary endpoint.
HK Stock
China Resources Gas (01193) spent 16.5474 million Hong Kong dollars to repurchase 1 million shares on June 16.
HK Stock
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.